Cédric Coulouarn

Cholangiocarcinoma 2026: status quo, unmet needs and priorities

Nature Reviews Gastroenterology & Hepatology 2025cited by 30position: middledoi

NADPH oxidase 1/4 dual inhibition impairs transforming growth factor-beta protumorigenic effects in cholangiocarcinoma cancer-associated fibroblasts

Signal Transduction and Targeted Therapy 2025cited by 7position: middledoi

Dual NOX4/NOX1 inhibition by setanaxib halts cholangiocarcinoma progression by impairing cancer associated fibroblast activation

Free Radical Biology and Medicine 2024cited by 0position: middledoi

Criteria for preclinical models of cholangiocarcinoma: scientific and medical relevance

Nature Reviews Gastroenterology & Hepatology 2023cited by 43position: middledoi

Clinical relevance of biomarkers in cholangiocarcinoma: critical revision and future directions

Gut 2022cited by 70position: middledoi

Wnt/β-Catenin-Pathway Alterations and Homologous Recombination Deficiency in Cholangiocarcinoma Cell Lines and Clinical Samples: Towards Specific Vulnerabilities

Journal of Personalized Medicine 2022cited by 7position: middledoi

The protease‐inhibitor SerpinB3 as a critical modulator of the stem‐like subset in human cholangiocarcinoma

Liver International 2021cited by 63position: middledoi

Cholangiocarcinoma 2020: the next horizon in mechanisms and management

Nature Reviews Gastroenterology & Hepatology 2020cited by 2,420position: middledoi

GDF11 exhibits tumor suppressive properties in hepatocellular carcinoma cells by restricting clonal expansion and invasion

Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2019cited by 43position: middledoi

TGF-β1 and TGF-β2 abundance in liver diseases of mice and men

Oncotarget 2016cited by 61position: middledoi

No grants ingested yet.

Isabel Fabregat · Centro de Investigación Biomédica en Red2 papers (2016–2024)Diego F. Calvisi · University of Sassari2 papers (2022–2024)Hanna Korhonen · University of Turku1 papers (2016–2016)Anne Dropmann · University Hospital Heidelberg1 papers (2016–2016)Florian Lüke · Hershey (United States)1 papers (2022–2022)— · 1 papers (2016–2016)— · 1 papers (2024–2024)Jochen Heß · German Cancer Research Center1 papers (2016–2016)— · 1 papers (2024–2024)Chiara Braconi · Beatson West of Scotland Cancer Centre1 papers (2022–2022)Rocı́o I.R. Macı́as · University of the Basque Country1 papers (2022–2022)— · 1 papers (2019–2019)Maria Guido · University of Padua1 papers (2022–2022)Felix Keil · University of Regensburg1 papers (2022–2022)Luis E. Gómez-Quiroz · Center for Cancer Research1 papers (2019–2019)Steven Dooley · University Hospital Heidelberg1 papers (2016–2016)Ester Gonzalez‐Sanchez · Institut d'Investigació Biomédica de Bellvitge1 papers (2024–2024)Eugenio Gaudio · University of Tennessee at Knoxville1 papers (2022–2022)Kirsten Utpatel · Federico II University Hospital1 papers (2022–2022)Maria Thomas · University of Regensburg1 papers (2016–2016)

Recent publications

Grants

Frequent collaborators